Company Patients Gateways News FAQs Contact Us Site Map
 
 
06/02/08 Jennerex Clinical Trial Data with JX-594 Selected for Plenary Session Presentation at Major International Conference
05/21/08 Jennerex Publishes Promising Results from Cancer Clinical Trial of
JX-594 in Lancet Oncology
11/08/07 Jennerex Appoints Bob Ingram Special Advisor and Hires Marty Glick as EVP, Corporate Strategy
10/23/07 Jennerex Presents Clinical Data From JX-594 Demonstrating Tumor Efficacy Against Advanced Liver Cancers
10/17/06 Jennerex and Green Cross Enter Agreement to Develop and Commercialize JX-594 In South Korea
 
 
Home | Innovation | Products | Expertise
Company | Physicians | Patients | Gateways | News | FAQs | Contact Us | Site Map
© 2007 Jennerex Biotherapeutics, Inc. | Site design by Heiney & Craig